Johnson & Johnson (JNJ) Net Income towards Common Stockholders (2009 - 2026)
Johnson & Johnson's Net Income towards Common Stockholders came in at $210 million for Q3 2026, down 95.9% from $5.15 billion a year earlier and down 96.2% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 27, 2026, Johnson & Johnson reported Net Income towards Common Stockholders of $16.1 billion, down 35.9% year-over-year; for FY2025, it was $26.8 billion, up 90.6% from FY2024.
- Net Income towards Common Stockholders carries a four-year compound annual growth rate of 16.2% (FY2021 to FY2025).
- Going back by year, Net Income towards Common Stockholders was $14.07 billion in FY2024 (-60.0%), $35.15 billion in FY2023 (+95.9%), $17.94 billion in FY2022 and $14.71 billion in FY2021.
- The Q3 2026 figure represents the lowest quarterly Net Income towards Common Stockholders since Q1 2023.
- Year-over-year, Net Income towards Common Stockholders has declined for three consecutive quarters, with growth averaging 29.1% over the last eight quarters.
- The fastest year-over-year change in Net Income towards Common Stockholders over five years came in Q1 2025 (growth of 237.9%), and the weakest in Q3 2026 (a decline of 95.9%).
- Business Quant data shows JNJ's Net Income towards Common Stockholders at $5.53 billion (Q2 2026), $5.24 billion (Q1 2026) and $5.12 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Vertex Pharmaceuticals | 132.74 Bn | 104.74 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 210.00 Mn |
| Jun 28, 2026 | 5.53 Bn |
| Mar 29, 2026 | 5.24 Bn |
| Dec 28, 2025 | 5.12 Bn |
| Sep 28, 2025 | 5.15 Bn |
| Jun 29, 2025 | 5.54 Bn |
| Mar 30, 2025 | 11.00 Bn |
| Dec 29, 2024 | 3.43 Bn |
| Sep 29, 2024 | 2.69 Bn |
| Jun 30, 2024 | 4.69 Bn |
| Mar 31, 2024 | 3.26 Bn |
| Dec 31, 2023 | 4.05 Bn |
| Oct 1, 2023 | 26.03 Bn |
| Jul 2, 2023 | 5.14 Bn |
| Apr 2, 2023 | -68.00 Mn |
| Jan 1, 2023 | 3.52 Bn |
| Oct 2, 2022 | 4.46 Bn |
| Jul 3, 2022 | 4.81 Bn |
| Apr 3, 2022 | 5.15 Bn |
| Oct 3, 2021 | 3.67 Bn |
API Access
Johnson & Johnson Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();